Clinical Trials · NCT01388361
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 413
- Start date
- Sep 2011
- Locations
- 124 sites, 12 countries
- Primary endpoint
- Change From Baseline in HbA1c (%) (Glycosylated Haemoglobin)